Furthermore, we applied a TGF-β neutralizing antibody to AD mice to check whether the inhibitory effect of the CD1dhiPD-L1hiCD27+ NK subsets was indeed TGF-β-dependent in vivo. Here, TGFB1 is linked to Alzheimer disease.